Effect of supplementation in treatment of patients with Parkinson's
Phase 2
Completed
- Conditions
- Parkinson disease.Parkinson disease
- Registration Number
- IRCT2017082434497N4
- Lead Sponsor
- Vice chancellor for research, Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with Parkinson's
Aged 50 to 90 years
Exclusion Criteria
Taking antioxidants supplements
Taking anti-inflammatory supplements
Depression
Severe psychosis
hypo- and hyperthyroidism
Smoking
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie probiotic effects on metabolic profiles in Parkinson's disease?
How does probiotic supplementation compare to standard-of-care treatments for Parkinson's disease in clinical trials?
Which biomarkers are associated with metabolic response to probiotic interventions in Parkinson's patients?
What adverse events are reported in probiotic trials for Parkinson's disease and how are they managed?
Are there synergistic effects of combining probiotics with MAO-B inhibitors or other Parkinson's therapies?